Onward Medical N.V.
Develops neurostimulation therapies to restore function for people with spinal cord injury.
ONWD | AS
Overview
Corporate Details
- ISIN(s):
- NL0015000HT4
- LEI:
- 9845007A2CC4C8BFSB80
- Country:
- Netherlands
- Address:
- Schimmelt 2, 5611ZX Eindhoven
- Website:
- https://www.onwd.com/
- Sector:
- Manufacturing
Description
Onward Medical is a neurotechnology company that develops therapies to restore movement, function, and independence for people with spinal cord injury (SCI). The company's commercial product, the ARC-EX System, is an external, non-invasive spinal cord stimulation therapy indicated to improve hand sensation and strength for individuals with chronic cervical SCI. The system is used in rehabilitation clinics and is also cleared for home use. Onward Medical is also advancing its investigational implantable platform, the ARC-IM System, which is designed to address other functional deficits, including blood pressure regulation, following spinal cord injury.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-04-25 07:04 | English | ZIP • 9.6 MB | |||
| 2024-04-02 09:21 |
ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System
|
English | PDF • 122.0 KB | ||
| 2024-03-26 07:47 |
ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public …
|
English | PDF • 137.8 KB | ||
| 2024-03-26 07:47 |
ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public …
|
English | PDF • 137.8 KB | ||
| 2024-03-22 07:47 |
ONWARD ® Medical Publishes Prospectus for Listing of New Shares
|
English | PDF • 151.7 KB | ||
| 2024-03-21 11:09 |
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Of…
|
English | PDF • 509.3 KB | ||
| 2024-03-21 11:09 |
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Of…
|
English | PDF • 405.6 KB | ||
| 2024-03-21 07:39 |
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Of…
|
English | PDF • 509.3 KB | ||
| 2024-03-21 07:37 |
ONWARD ® Medical Successfully Raises 20 Million in a Capital Increase by Way of…
|
French | PDF • 320.3 KB | ||
| 2024-03-21 07:37 |
ONWARD ® Medical Successfully Raises 20 Million in a Capital Increase by Way of…
|
English | PDF • 270.3 KB | ||
| 2024-03-18 07:47 |
ONWARD® Medical Successfully Completes Benchmark Testing on Path to Commerciali…
|
English | PDF • 119.3 KB | ||
| 2024-03-15 07:44 |
ONWARD® Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Relea…
|
English | PDF • 144.8 KB | ||
| 2023-11-16 08:22 |
ONWARD® Reports Q3 Business Update and Year-To-Date Highlights
|
English | PDF • 196.9 KB | ||
| 2023-09-19 06:52 | English | PDF • 8.5 MB | |||
| 2023-05-08 16:40 |
ONWARD Announces Results of Annual General Meeting of Shareholders
|
English | PDF • 128.5 KB |
Automate Your Workflow. Get a real-time feed of all Onward Medical N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Onward Medical N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Onward Medical N.V. via our API.
Peer Companies
